Our top pick for
Centric Brands Inc is an apparel manufacturing business based in the US. Centric Brands shares (CTRC) are listed on the NASDAQ and all prices are listed in US Dollars.
|52-week range||$0.02 - $0.02|
|50-day moving average||$0.03|
|200-day moving average||$0.23|
|Wall St. target price||$8.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-6.31|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Centric Brands stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Centric Brands's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Centric Brands's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $148.2 million.
The EBITDA is a measure of a Centric Brands's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$2.1 billion|
|Operating margin TTM||2.86%|
|Gross profit TTM||$184.3 million|
|Return on assets TTM||3.3%|
|Return on equity TTM||0%|
|Market capitalisation||$9.7 million|
TTM: trailing 12 months
There are currently 478,836 Centric Brands shares held short by investors – that's known as Centric Brands's "short interest". This figure is 8.6% up from 441,027 last month.
There are a few different ways that this level of interest in shorting Centric Brands shares can be evaluated.
Centric Brands's "short interest ratio" (SIR) is the quantity of Centric Brands shares currently shorted divided by the average quantity of Centric Brands shares traded daily (recently around 342025.71428571). Centric Brands's SIR currently stands at 1.4. In other words for every 100,000 Centric Brands shares traded daily on the market, roughly 1400 shares are currently held short.
However Centric Brands's short interest can also be evaluated against the total number of Centric Brands shares, or, against the total number of tradable Centric Brands shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Centric Brands's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Centric Brands shares in existence, roughly 10 shares are currently held short) or 0.0433% of the tradable shares (for every 100,000 tradable Centric Brands shares, roughly 43 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Centric Brands.
Find out more about how you can short Centric Brands stock.
We're not expecting Centric Brands to pay a dividend over the next 12 months.
Centric Brands's shares were split on a 1:30 basis on 28 January 2016. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Centric Brands shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Centric Brands shares which in turn could have impacted Centric Brands's share price.
Over the last 12 months, Centric Brands's shares have ranged in value from as little as $0.0161 up to $0.0161. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Centric Brands's is 0.9014. This would suggest that Centric Brands's shares are less volatile than average (for this exchange).
Centric Brands Inc. designs, produces, merchandises, manages, markets, and distributes kid's wear, and women's and men's accessories and apparel in North America and international markets. The company also licenses approximately 100 brands across its core product categories, including kid's, women's, and men's accessories and apparel. Its owned brands include Hudson, a designer and marketer of women's and men's branded denim and apparel; Robert Graham, an eclectic apparel and accessories brand; and SWIMS, a Scandinavian lifestyle brand for a range of footwear, apparel, and accessories. The company sells its products through its owned retail stores, e-commerce Websites, retail partners' Websites, and partner shop-in-shops, as well as to department, specialty, and mass merchant retail stores. It operates retail stores for its Robert Graham and SWIMS brands. As of May 15, 2019, the company operated 31 Robert Graham brand stores, which consisted of 19 full price stores and 12 outlet stores; and 3 SWIMS brand outlet stores, which consisted of 1 full price store and 2 outlet stores.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.